{"podcast":{"title":"from Dreamers to Disruptors","slug":"from-dreamers-to-disruptors-7329003","podcast_index_feed_id":7329003,"rss_url":"https://media.rss.com/from-dreamers-to-disruptors/feed.xml","website_url":"https://rss.com/podcasts/from-dreamers-to-disruptors","image_url":"https://media.rss.com/from-dreamers-to-disruptors/20250509_090518_5f22b7c3b5016d78d606bc840d8a73d9.png","author":"Medidata","episode_count":14,"summary":"This is a call to the world’s visionaries who made waves. The ones who gave themselves the green light to turn bold dreams into disruptive realities and shake up the status quo. Hear straight from industry leaders across tech, healthcare, and life sciences as they share their stories and innovations with us. This is from Dreamers to Disruptors , a podcast by Medidata.","last_synced_at":"2026-07-14T08:20:02.059953+00:00","page_url":"https://stenobird.com/podcast/from-dreamers-to-disruptors-7329003"},"episode":{"title":"DTRA’s Craig Lipset on Decentralized Trials and Accelerating Rare Disease Research","slug":"dtra-s-craig-lipset-on-decentralized-trials-and-accelerating-rare-disease-research","published_at":"2026-07-13T18:01:41+00:00","page_url":"https://stenobird.com/podcast/from-dreamers-to-disruptors-7329003/dtra-s-craig-lipset-on-decentralized-trials-and-accelerating-rare-disease-research","show_page_url":"https://stenobird.com/podcast/from-dreamers-to-disruptors-7329003","url":"https://rss.com/podcasts/from-dreamers-to-disruptors/2985218","audio_url":"https://content.rss.com/episodes/329244/2985218/from-dreamers-to-disruptors/2026_07_13_15_37_35_a55d679c-9dbf-40a8-a1ca-9ff53bea448d.mp3","summary":"New technologies have always driven advances in clinical research, and that’s still true today. The Covid pandemic rapidly accelerated the adoption of decentralized trials, powered by emerging health tech, but in less dramatic times, life sciences must find ways to ensure continued innovation. As an industry veteran and co-chair of the Digital Trials & Research Alliance (DTRA), Craig Lipset has a powerful perspective on the potential of emerging technologies, and how to successfully combat inertia and encourage adoption in clinical studies. He joins Medidata CEO Anthony Costello to explore the origins of decentralized trials, the potential of Virtual Twins, and how the Buffalo Initiative is promoting research into understudied rare diseases. Visit our website Read our blog Follow Medidata: LinkedIn , Instagram , X , YouTube Follow Anthony: LinkedIn Follow Craig: LinkedIn","meta_description":"New technologies have always driven advances in clinical research, and that’s still true today. The Covid pandemic rapidly accelerated the adoption of dec…","key_points":[],"chapters":[],"topics":[],"duration_seconds":3954,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/from-dreamers-to-disruptors-7329003/episodes/dtra-s-craig-lipset-on-decentralized-trials-and-accelerating-rare-disease-research/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/from-dreamers-to-disruptors-7329003/dtra-s-craig-lipset-on-decentralized-trials-and-accelerating-rare-disease-research.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]}}